Crinetics Pharmaceuticals (CRNX) Gross Margin (2025 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly Gross Margin came in at 98.14% in Q1 2026, down 186.0% year-on-year from 114.11% in Q1 2025, and down 1.86% quarter-over-quarter from 100.0% in Q1 2025.
Crinetics Pharmaceuticals (CRNX) Gross Margin (2025 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Gross Margin history runs 2 years deep, the most recent figure standing at 98.14% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 90.68% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 82.22% |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.44 Bn | 10.53 Mn | 98.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.14% |
| Mar 31, 2025 | 100.00% |